1. Prognosis in hypertrophic cardiomyopathy. Role of age and clinical, electrocardiographic and haemodynamic features;McKenna, W.I.; Deanfield, J.; Faruqui, A.; England, D.; Oakley, C.; Goodwin, J.;Am Y Cardiol,1981
2. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy;Stafford, W.I.; Trohman, R.G.; Bilsker, M.; Zaman, L.; Catellanos, A.; Myerburg, R.J.;YAm Coil Cardiol,1986
3. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy;Cannon, R.O.; Dilsizian, V.; O'Gara, P.; Udelson, J.E.; Schenke, W.H.; Quyyumi, A.;Circulation,1991
4. Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteriograms;Pasternac, A.; Noble, J.; Streulens, Y.; Elie, R.; Henschke, C.; Bourassa, M.G.;Circulation,1982
5. Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy;Pitcher, D.; Wainwright, R.; Maisey, M.; Curry, P.; Sowton, E.;BrHeartJ,1980